A physiological role for flavin-containing monooxygenase (FMO3) in humans?

References

• Allerston CK, Shimizu M, Fujieda M, Shephard EA, Yamazaki H, Phillips IR. (2007). Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3). Pharmacogenet Genomics 17:827–39.
   PubMed Web of Science ®Google Scholar
• Ayesh R, Mitchell SC, Smith RL. (1995). Dysfunctional N-oxidation of trimethylamine and the influence of testosterone treatment in man. Pharmacogenetics 5:244–6.
   PubMedGoogle Scholar
• Ayesh R, Mitchell, SC, Zhang A, Smith RL. (1993). The fish-odour syndrome: biochemical, familial and clinical aspects. Br Med J 307:655–7.
   PubMed Web of Science ®Google Scholar
• Barber M, Conrad ME, Umbreit JN, Barton JC, Moore EG. (2000). Abnormalities of flavin monooxygenase as an etiology for sideroblastic anemia. Am J Hematol 65:149–53.
   PubMed Web of Science ®Google Scholar
• Boriss H, Boersma M, Wiltshire KH. (1999). Trimethylamine induces vertical migration in Daphnia. Nature 398:382.
   Web of Science ®Google Scholar
• Cashman JR. (2002a). Human and plant flavin-containing monooxygenase N-oxygenation of amines: detoxication vs bioactivation. Drug Metab Rev 34:513–12.
   PubMed Web of Science ®Google Scholar
• Cashman JR. (2002b). Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics 3:325–39.
   PubMed Web of Science ®Google Scholar
• Conan Doyle A. (1892). ‘The Adventure of Silver Blaze’. The Strand Magazine, 24 December 1982, 4:645–660(George Newnes Ltd, London).
   Google Scholar
• Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. (1997). Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet 17:491–4.
   PubMed Web of Science ®Google Scholar
• Duffel MW, Graham JM, Ziegler DM. (1981). Changes in dimethylaniline N-oxidase activity of mouse liver and kidney induced by steroid sex hormones. Mol Pharmacol 19:134–9.
   PubMed Web of Science ®Google Scholar
• Elfarra AA. (1995). Potential role of the flavin-containing monooxygenases in the metabolism of endogenous compounds. Chem Biol Interact 96:47–55.
   PubMed Web of Science ®Google Scholar
• Falls JG, Ryu DY, Cao Y, Levi PE, Hodgson E. (1997). Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 342:212–23.
   PubMed Web of Science ®Google Scholar
• Gervasini G, Carrillo JA, Benitez J. (2004). Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds. Clin Pharmacokinet 43:693–706.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Wu ZL, Bartleson CJ. (2005). Function of human cytochromes P450s: characterization of the orphans. Biochem Biophys Res Commun 338:465–9.
   PubMed Web of Science ®Google Scholar
• Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR. (2003). Trimethylaminuria and a human FMO3 mutation database. Hum Mutat 22:209–13.
   PubMed Web of Science ®Google Scholar
• Ioannides C. (2002). Xenobiotic metabolism: an overview. In: Ioannides C, ed. Enzyme systems that metabolise drugs and other xenobiotics. Chichester: Wiley & Sons, 1–32.
   Google Scholar
• Kim YH, Lim DS, Lee JY, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. (2003). Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35:336–49.
   PubMed Web of Science ®Google Scholar
• Klick DE, Hines RN. (2007). Mechanisms regulating human FMO3 transcription. Drug Metab Rev 39:419–42.
   PubMed Web of Science ®Google Scholar
• Klick DE, Shadley JD, Hines RN. (2008). Differential regulation of human hepatic flavin-containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins. Biochem Pharmacol 76:268–78.
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. (2002). Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236–43.
   PubMed Web of Science ®Google Scholar
• Krueger SK, Williams DE, Yuch MF, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR. (2002). Genetic polymorphisms of flavin-containing monooxygenase (FMO). Drug Metab Rev 34:523–32.
   PubMed Web of Science ®Google Scholar
• Lattard V, Laucher J, Buronfosse T, Garnier F, Benoit E. (2002a). Physiological factors affecting the expression of FMO1 and FMO3 in the rat liver and kidney. Biochem Pharmacol 63:1453–64.
   PubMed Web of Science ®Google Scholar
• Lattard V, Longin-Sauvageon C, Kruger SK, Williams DE, Benoit E. (2002b). The FMO2 gene of laboratory rats, as in most humans, encodes a truncated protein. Biochem Biophys Res Commun 292:558–63.
   PubMed Web of Science ®Google Scholar
• Lee MY, Clark JE, Williams DE. (1993). Induction of flavin-containing monooxygenase (FMO B) in rabbit lung and kidney by sex steroids and glucocorticoids. Arch Biochem Biophys 302:332–6.
   PubMed Web of Science ®Google Scholar
• Lee MY, Smiley S, Kadkhodayan S, Hines RN, Williams DE. (1995). Developmental regulation of flavin-containing monooxygenase (FMO) isoforms 1 and 2 in pregnant rabbit. Chem Biol Interact 96:75–85.
   PubMed Web of Science ®Google Scholar
• Liberles SD. (2009). Trace amine-associated receptors are olfactory receptors in vertebrates. Ann NY Acad Sci 1170:168–72.
   PubMed Web of Science ®Google Scholar
• Liberles SD, Buck LB. (2006). A second class of chemosensory receptors in the olfactory epithelium. Nature 422:645–50.
   Google Scholar
• Mitchell SC. (2008). Flavin mono-oxygenase (FMO)—the ‘other’ oxidase. Curr Drug Metab 9:280–4.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Bollard ME, Zhang AQ. (2007). Short-chain aliphatic amines in human urine: A mathematical examination of metabolic interrelationships. Metabolism 56:19–23.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Smith RL. (2001). Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos 29:517–21.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Smith RL. (2003). Trimethylamine and odorous sweat. J Inherit Metab Dis 26:415–16.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Smith RL, Waring RH. (2009). The menstrual cycle and drug metabolism. Curr Drug Metab 10:499–507.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Steventon GB. (2006). Drug metabolism and toxicity: hijacking enzymes of intermediary metabolism. Curr Top Toxicol 3:57–63.
   Google Scholar
• Mitchell SC, Zhang AQ. (2001). Methylamine in human urine. Clin Chim Acta 312:107–14.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Zhang AQ, Smith RL. (1998). Towards the next millennium: Pharmacogenetics. In: Gooderham N, Jenner P, Patterson L. eds. Drug metabolism: Towards the next millennium. Amsterdam: IOS Press, 119–26.
   Google Scholar
• Papadopoulos NT, Katsoyannos BI., Kouloussis NA, Hendrichs J, Carey JR, Heath RR. (2001). Early detection and population monitoring of Ceratitis capitata (Diptera: Tephritidae) in a mixed-fruit orchard in northern Greece. J Econ Entomol 94:971–8.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Cashman JR, Yamazaki H. (2007). Transient trimethylaminuria related to menstruation. BMC Med Genet 8:2.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Murayama N, Nagashima S, Fujieda M, Yamazaki H. (2008). Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5′-upstream distal region and common element in proximal region. Drug Metab Pharmacokinet 23:54–8.
   PubMed Web of Science ®Google Scholar
• Takamura T, Sakurai M, Ota T, Ando H, Honda M, Kaneko S. (2004). Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. Diabetologia 47:638–47.
   PubMed Web of Science ®Google Scholar
• Todd WA. (1979). Psychosocial problems as the major complication of an adolescent with trimethylaminuria. J Pediatr 94:936–7.
   PubMed Web of Science ®Google Scholar
• Tynes RE, Sabourin PJ, Hodgson E. (1985). Identification of distinct hepatic and pulmonary forms of microsomal flavin-containing monooxygenase in the mouse and rabbit. Biochem Biophys Res Commun 126:1069–75.
   PubMed Web of Science ®Google Scholar
• Umbreit JN, Conrad ME, Moore EG, Desai MP, Turrens J. (1996). Paraferritin: a protein complex with ferrireductase activity is associated with iron absorption in rats. Biochemistry 35:6460–9.
   PubMed Web of Science ®Google Scholar
• Van Thriel C, Shäper M, Kieswetter E, Kleinbeck S, Juran S, Blaszkewicz M, Fricke HH, Altmann L, Berresheim H, Brüning T. (2006). From chemosensory thresholds to whole body exposure—experimental approaches evaluating chemosensory effects of chemicals. Int Arch Occ Environ Health 79:308–21.
   PubMed Web of Science ®Google Scholar
• Williams DE, Ziegler DM, Nordin DJ, Hale SE, Masters BS. (1984). Rabbit lung flavin-containing monooxygenase is immunochemically and catalytically distinct from the liver enzyme. Biochem Biophys Res Commun 125:116–22.
   PubMed Web of Science ®Google Scholar
• Wirth PG, Thorgeirsson SS. (1978). Amine oxidase in mice—sex differences and developmental aspects. Biochem Pharmacol 27:601–3.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shimizu M. (2007). Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients. Curr Drug Metab 8:487–91.
   PubMed Web of Science ®Google Scholar
• Zhang AQ, Mitchell SC, Ayesh R, Smith RL. (1992). Determination of trimethylamine and related aliphatic amines in human urine by head-space gas chromatography. J. Chromatogr 582:141–5.
   Google Scholar
• Zhang AQ, Mitchell SC, Smith RL. (1996a). Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet 348:1740–1.
   PubMed Web of Science ®Google Scholar
• Zhang AQ, Mitchell SC, Smith RL. (1996b). Discontinuous distribution of N-oxidation of dietary-derived trimethylamine in a British population. Xenobiotica 26:957–61.
   PubMed Web of Science ®Google Scholar
• Ziegler DM. (1985). Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem 54:305–29.
   PubMed Web of Science ®Google Scholar
• Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E. (1999). Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet 354:834–5.
   PubMed Web of Science ®Google Scholar